368 related articles for article (PubMed ID: 22271902)
41. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
Babushok DV; Bessler M; Olson TS
Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
[TBL] [Abstract][Full Text] [Related]
42. Germline GATA2 Mutation and Bone Marrow Failure.
McReynolds LJ; Calvo KR; Holland SM
Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
[TBL] [Abstract][Full Text] [Related]
43. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
[TBL] [Abstract][Full Text] [Related]
44. Somatic genetic alterations predict hematological progression in GATA2 deficiency.
Largeaud L; Collin M; Monselet N; Vergez F; Fregona V; Larcher L; Hirsch P; Duployez N; Bidet A; Luquet I; Bustamante J; Dufrechou S; Prade N; Nolla M; Hamelle C; Tavitian S; Habib C; Meynier M; Bellanne-Chantelot C; Donadieu J; De Fontbrune FS; Fieschi C; Ferster A; Delhommeau F; Delabesse E; Pasquet M
Haematologica; 2023 Jun; 108(6):1515-1529. PubMed ID: 36727400
[TBL] [Abstract][Full Text] [Related]
45. Hereditary Predispositions to Myelodysplastic Syndrome.
Bannon SA; DiNardo CD
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27248996
[TBL] [Abstract][Full Text] [Related]
46. High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML.
Simon L; Spinella JF; Yao CY; Lavallée VP; Boivin I; Boucher G; Audemard E; Bordeleau ME; Lemieux S; Hébert J; Sauvageau G
Blood; 2020 May; 135(21):1882-1886. PubMed ID: 32315381
[TBL] [Abstract][Full Text] [Related]
47. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
[TBL] [Abstract][Full Text] [Related]
48. A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability.
Fox LC; Tan M; Brown AL; Arts P; Thompson E; Ryland GL; Lickiss J; Scott HS; Poplawski NK; Phillips K; Came NA; James P; Ting SB; Ritchie DS; Szer J; Hahn CN; Schwarer A; Blombery P
Br J Haematol; 2020 Sep; 190(5):e297-e301. PubMed ID: 32488879
[No Abstract] [Full Text] [Related]
49. GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
Rajput RV; Arnold DE
Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
[TBL] [Abstract][Full Text] [Related]
50. Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.
Bortnick R; Wlodarski M; de Haas V; De Moerloose B; Dworzak M; Hasle H; Masetti R; Starý J; Turkiewicz D; Ussowicz M; Kozyra E; Albert M; Bader P; Bordon V; Cario G; Beier R; Schulte J; Bresters D; Müller I; Pichler H; Sedlacek P; Sauer MG; Zecca M; Göhring G; Yoshimi A; Noellke P; Erlacher M; Locatelli F; Niemeyer CM; Strahm B;
Bone Marrow Transplant; 2021 Nov; 56(11):2732-2741. PubMed ID: 34244664
[TBL] [Abstract][Full Text] [Related]
51. [Alert in germline mutation predisposed to myeloid neoplasm: myelodysplastic syndromes accompanied with GATA2 deficeincy syndrome].
Yao H; Yang X; Zhang X; Wang P; Deng XJ; Luo ML; Chen T; Liu YQ; Feng YM; Gao L; Kong PY
Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):1042-1045. PubMed ID: 35045679
[No Abstract] [Full Text] [Related]
52. Familial myelodysplastic syndromes: a review of the literature.
Liew E; Owen C
Haematologica; 2011 Oct; 96(10):1536-42. PubMed ID: 21606161
[TBL] [Abstract][Full Text] [Related]
53. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
Tawana K; Drazer MW; Churpek JE
Leukemia; 2018 Jul; 32(7):1482-1492. PubMed ID: 29483711
[TBL] [Abstract][Full Text] [Related]
54. A case of GATA2-related myelodysplastic syndrome with unbalanced translocation der(1;7)(q10;p10).
Kurata T; Shigemura T; Muramatsu H; Okuno Y; Nakazawa Y
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28066994
[No Abstract] [Full Text] [Related]
55. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
Shimizu R; Yamamoto M
IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
[TBL] [Abstract][Full Text] [Related]
56. GATA2 mutations lead to MDS and AML.
Hyde RK; Liu PP
Nat Genet; 2011 Sep; 43(10):926-7. PubMed ID: 21956389
[No Abstract] [Full Text] [Related]
57. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
[TBL] [Abstract][Full Text] [Related]
58. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
[TBL] [Abstract][Full Text] [Related]
59. Familial predisposition of myeloid malignancies: biological and clinical significance of recurrent germ line mutations.
Matsui H
Int J Hematol; 2017 Aug; 106(2):160-162. PubMed ID: 28631176
[No Abstract] [Full Text] [Related]
60. Somatic mutations in children with
Fisher KE; Hsu AP; Williams CL; Sayeed H; Merritt BY; Elghetany MT; Holland SM; Bertuch AA; Gramatges MM
Blood Adv; 2017 Feb; 1(7):443-448. PubMed ID: 29296959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]